( CNN) Male between the senilities of 55 and 69 — particularly those at high-risk for prostate cancer — should talk to their physicians about the pros and cons of prostate cancer screening, according to new guidelines released Tuesday.
The guidelines, publicized Tuesday in the periodical JAMA, come from the US Preventive Assistance Task Force, an independent body of experts that makes recommendations to the American world about preventive works. They are an update to previous recommendations published in 2012 thatrecommended against routine screening because of the risk involved in additional testing and management.
But according to new research, prostate-specific antigen( PSA) -based screening for men in the 55 to 69 age group could impede 1.3 deaths and 3 cases of cancer metastases for every 1,000 humanities screened. Hence, the task force concluded that screening does make sense for men in that age group, but that they should be aware of the potential risks associated with additional testing.